Merck's Keytruda wins FDA approval as combination therapy for kidney cancer

📆 4/22/2019 2:13 PM
📰 ChannelNewsAsia

⏱ Reading Time:
8 sec. here
2 min. at publisher
📊 Quality Score:
News: 6%
Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously ...

The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients with the most common type of kidney cancer, the company said on Monday.

FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cancer centre’s move to oust Chinese scientists ‘will backfire on US’Chinese state media and researchers have lashed out at a prominent US cancer centre’s decision to oust three scientists over alleged links to espionage, saying such moves would backfire on America. Peter Pisters, president of the MD Anderson Cancer Centre, told the The Houston Chronicle on Friday that
Source: YahooSG - 🏆 3. / 71 Read more »